What is the clinical and cost effectiveness of coronary revascularisation with coronary artery bypass grafting or angioplasty in people with heart failure?
Current evidence indicates that coronary revascularisation with coronary artery bypass grafting or angioplasty may be beneficial in people with heart failure with reduced ejection fraction (HFREF). Randomised studies have suggested that patients who derive the most benefit from surgical intervention are those with impaired left ventricular function. However, the effectiveness of revascularisation in HFREF varies depending on the individual patient characteristics and local expertise. It is recommended that patients with HFREF and severe CAD should be considered for revascularisation on an individual basis. 